Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Nature ; 435(7040): 347-53, 2005 May 19.
Artigo em Inglês | MEDLINE | ID: mdl-15902258

RESUMO

Platelet-derived growth factor (PDGF) is a potent mitogenic and migratory factor that regulates the tyrosine phosphorylation of a variety of signalling proteins via intracellular production of H2O2 (refs 1, 2-3). Mammalian 2-Cys peroxiredoxin type II (Prx II; gene symbol Prdx2) is a cellular peroxidase that eliminates endogenous H2O2 produced in response to growth factors such as PDGF and epidermal growth factor; however, its involvement in growth factor signalling is largely unknown. Here we show that Prx II is a negative regulator of PDGF signalling. Prx II deficiency results in increased production of H2O2, enhanced activation of PDGF receptor (PDGFR) and phospholipase Cgamma1, and subsequently increased cell proliferation and migration in response to PDGF. These responses are suppressed by expression of wild-type Prx II, but not an inactive mutant. Notably, Prx II is recruited to PDGFR upon PDGF stimulation, and suppresses protein tyrosine phosphatase inactivation. Prx II also leads to the suppression of PDGFR activation in primary culture and a murine restenosis model, including PDGF-dependent neointimal thickening of vascular smooth muscle cells. These results demonstrate a localized role for endogenous H2O2 in PDGF signalling, and indicate a biological function of Prx II in cardiovascular disease.


Assuntos
Neovascularização Fisiológica/efeitos dos fármacos , Peroxidases/metabolismo , Fator de Crescimento Derivado de Plaquetas/farmacologia , Transdução de Sinais/efeitos dos fármacos , Animais , Aorta/citologia , Artérias Carótidas/metabolismo , Artérias Carótidas/patologia , Células Cultivadas , Reestenose Coronária/metabolismo , Reestenose Coronária/patologia , Ativação Enzimática , Humanos , Camundongos , Miócitos de Músculo Liso/citologia , Peroxidases/deficiência , Peroxidases/genética , Peroxirredoxinas , Fosforilação/efeitos dos fármacos , Fosfotirosina/metabolismo , Ligação Proteica , Receptores do Fator de Crescimento Derivado de Plaquetas/metabolismo
2.
Biochem Biophys Res Commun ; 399(4): 607-12, 2010 Sep 03.
Artigo em Inglês | MEDLINE | ID: mdl-20682286

RESUMO

The Gram-negative bacterium Vibrio vulnificus produces cytotoxins that induce the acute death of host cells. However, the secretory mechanisms of such cytotoxins have not been extensively studied. Previously, we reported that substantial amounts of V. vulnificus cytolysin-hemolysin (VvhA) are produced in vivo during the bacterial infection in mice and that this cytotoxin, in conjunction with RtxA1, mediates cytotoxicity. In this study, we investigated whether V. vulnificus cells release outer membrane vesicles (OMVs), which are used by some Gram-negative bacteria to deliver virulence factors into host cells. We found that V. vulnificus produce OMVs and that these vesicles can induce host cell death. This process appears to be mediated by VvhA, as evidenced by the finding that OMVs isolated from VvhA-null mutants do not induce cytotoxicity. In addition, cholesterol sequestration in the host cells prevents OMV-mediated VvhA delivery, indicating that VvhA-bearing OMVs interact with cholesterol on the host cell surface. Furthermore, intracellular expression experiments revealed that VvhA-mediated cytotoxicity is driven by its N-terminal leukocidin domain.


Assuntos
Apoptose , Citotoxinas/metabolismo , Vesículas Transportadoras/metabolismo , Vibrio vulnificus/patogenicidade , Fatores de Virulência/metabolismo , Animais , Proteínas de Bactérias/metabolismo , Membrana Celular/metabolismo , Colesterol/metabolismo , Células Epiteliais/metabolismo , Células HeLa , Humanos , Camundongos , Transporte Proteico , Vibrio vulnificus/metabolismo
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa